Weiguo Cao - School of Medicine, Shanghai Jiao Tong University

基本信息

浏览量：17

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Response-adapted Zanubrutinib and Tislelizumab As a Potential Strategy to Enhance CD19 CAR T-cell Therapy in Relapsed/refractory Large B-cell Lymphoma: A Retrospective Observational Study

Rong Shen,Wei-Guo Cao,Li Wang, Ling-Shuang Sheng, Yi-Lun Zhang,Wen Wu, Peng-Peng Xu,Shu Cheng, Meng-Ke Liu, Yan Dong, Yue Wang,Xiang-Qin Weng,Xu-Feng Jiang,Qi Song,Hong-Mei Yi, Lei Li,Sheng Chen, Zi-Xun Yan,Wei-Li Zhao

Clinical and translational medicineno. 4 (2025): e70310-e70310

引用0浏览0WOS引用

LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study

Lingshuang Sheng,Zixun Yan,Li Wang, Wen Wu,Yilun Zhang,Rong Shen,Weiguo Cao, Lei Li,Sheng Chen,Xufeng Jiang,Hongmei Yi,Qi Song,Shu Cheng,Pengpeng Xu,Xuanming Yang, Yuxiang Zhu, Xikang Xu, Fuzhe Wang,Jianyong Li,Wei Li Zhao

Bloodno. Supplement 1 (2024): 4822-4822

引用0浏览0引用

Anti-metabolic Agent Pegaspargase Plus PD-1 Antibody Sintilimab for First-Line Treatment in Advanced Natural Killer T Cell Lymphoma

Jie Xiong,Shu Cheng, Xiao Gao,Shan-He Yu,Yu-Ting Dai,Xin-Yun Huang,Hui-Juan Zhong,Chao-Fu Wang,Hong-Mei Yi, Hao Zhang,Wei-Guo Cao,Rong Li,Wei Tang,Yan Zhao,Peng-Peng Xu,Li Wang,Wei-Li Zhao

Signal Transduction and Targeted Therapyno. 1 (2024)

引用1浏览0WOSNATURE引用

Toripalimab Combined with Definitive Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients (TRACE): A Single-Arm, Phase I/II Trial

Dan Ou,Rong Cai,Wei-Xiang Qi, Can Cui,Lu Cao,Shu-Bei Wang,Huan Li,Tao Ma, Ying Miao,Cheng Xu,Gang Cai,Wei-Guo Cao,Yun-Sheng Gao,Jia-Yi Chen,Hao-Ping Xu

CANCER IMMUNOLOGY IMMUNOTHERAPY（2024）

引用0浏览0WOS引用

Racial and Social-Economic Inequalities in Systemic Chemotherapy Use among Adult Glioblastoma Patients Following Surgery and Radiotherapy

Fei Xu,Xin Hua,Mengdi Wang,Weiguo Cao,Shubei Wang, Cheng Xu,Jiayi Chen,Yunsheng Gao, Linlin Chen,Weiqiong Ni

Scientific Reportsno. 1 (2024)

引用0浏览0WOSNATURE引用

Treatment Outcomes and Prognostic Factors of Chemotherapy Combined with Radiation Therapy for Patients with Early-Stage Extranodal Natural Killer/T-Cell Lymphoma

Shu-Bei Wang,Jia-Yi Chen,Wei-Li Zhao,Cheng Xu,Wei-Guo Cao,Yi-Min Han,Shu Cheng,Peng-Peng Xu,Hui-Juan Zhong,Gang Cai

ADVANCES IN RADIATION ONCOLOGYno. 12 (2024)

引用0浏览0WOS引用

A Phase 1 Study of LY007, a Novel Anti-Cd20 CAR-T Cell Therapy in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Zixun Yan,Lingshuang Sheng,Li Wang,Wen Wu,Yilun Zhang,Rong Shen,Weiguo Cao, Lei Li, Sheng Chen,Xufeng Jiang,Hongmei Yi,Qi Song,Shu Cheng,Peng-Peng Xu,Jianyong Li,Weili Zhao

Journal of Clinical Oncologyno. 16_suppl (2024): 7027-7027

引用0浏览0引用

Identification of Patients with Locally Advanced Rectal Cancer Eligible for Neoadjuvant Chemotherapy Alone: Results of a Retrospective Study

Yi-min Han,Wei-xiang Qi,Shu-bei Wang,Wei-guo Cao,Jia-yi Chen,Gang Cai

CANCER MEDICINE（2023）

引用1浏览0WOS引用

A Single Center Retrospective Study Assessing the Prognostic Significance of Pre-Treatment Neutrophil/lymphocyte Ratio in Locally Advanced Nasopharyngeal Carcinoma

Fei Xu,Weiqiong Ni,Xin Hua,Cheng Xu,Jiayi Chen,Weiguo Cao,Yunsheng Gao

Translational Cancer Research（2023）

引用2浏览0WOS引用

Treatment Outcomes and Prognostic Factors of Chemotherapy Combined with Radiotherapy for Patients with Stage I-II Nasal-Type Natural Killer/T-Cell Lymphoma

S. Wang,D. Ou,L. Cao, C. Xu,W. Cao, J. Chen,G. Cai

International Journal of Radiation OncologyBiologyPhysics（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn